WHO Warns of Growing Ebola Outbreak in Congo

The World Health Organization (WHO) has raised concerns over a rapidly evolving Ebola outbreak in the Democratic Republic of Congo (DRC), warning that the virus may have been circulating for months before detection and could continue to expand in the coming weeks.

Outbreak Likely Began Months Before Detection

Health experts from the WHO believe that the ongoing Ebola outbreak in eastern Democratic Republic of Congo may have started at least two months ago. This assessment comes after analyzing the scale and spread of infections, which indicate that the virus had been circulating undetected for a significant period.

Anais Legand, a WHO technical officer specializing in viral threats, stated that investigations are still underway to determine the exact origin and timeline of the outbreak. However, the number of cases suggests that transmission began well before it was officially identified.

Previously, the WHO had highlighted a “critical four-week detection gap” between the onset of symptoms in the first known patient and the laboratory confirmation of Ebola. This delay allowed the virus to spread silently across communities.

Rare Bundibugyo Strain Raises Alarm

The outbreak has been linked to the Bundibugyo strain of the Ebola virus, a relatively rare variant. Unlike the more commonly seen Zaire strain, the Bundibugyo strain currently has no approved vaccines or targeted treatments.

This lack of medical countermeasures has heightened concerns among global health experts. The inability to deploy vaccines immediately makes containment efforts more challenging, particularly in densely populated areas where the virus can spread rapidly.

The WHO estimates that the fatality rate of this strain is around 40 percent, making it a serious public health threat.

Rising Cases and Death Toll

The outbreak has already resulted in a significant number of suspected cases and deaths. According to WHO Director-General Tedros Adhanom Ghebreyesus, approximately 600 suspected infections and 139 suspected deaths have been recorded so far.

Out of these, 51 cases have been confirmed through laboratory testing in Congo. Additionally, two confirmed cases have been reported in neighboring Uganda, raising concerns about cross-border transmission.

The growing number of infections highlights the urgency of strengthening surveillance, testing, and treatment efforts to prevent further escalation.

Declared a Public Health Emergency

The WHO has classified the outbreak as a Public Health Emergency of International Concern (PHEIC). However, it has clarified that the situation does not currently qualify as a global pandemic emergency.

Tedros Adhanom Ghebreyesus took the unusual step of declaring the emergency before consulting the WHO Emergency Committee, citing the urgent nature of the situation. The committee later met and supported the classification.

The WHO currently assesses the risk level as high at both national and regional levels, while maintaining that the global risk remains relatively low.

Challenges in Containment Efforts

Efforts to contain the outbreak are being hampered by significant logistical and resource constraints. First responders in affected regions have reported shortages of essential supplies, including painkillers, protective equipment like face masks, and even basic transportation such as motorcycles.

These limitations are severely impacting the ability of health workers to trace contacts, isolate infected individuals, and provide adequate care. Contact tracing, which is critical in controlling Ebola outbreaks, becomes particularly difficult in areas with limited infrastructure.

The delayed detection of the outbreak has further complicated containment, as many transmission chains remain unidentified.

Possible Super-Spreader Event

WHO experts suspect that a super-spreader event may have played a role in accelerating the outbreak. Initial findings suggest that the virus may have spread rapidly following a funeral or within a healthcare facility.

Such events are known to significantly amplify transmission, especially in communities where close contact with infected individuals occurs. The first suspected Ebola-related death in this outbreak was reported on April 20, which may have been linked to subsequent rapid spread.

Understanding these transmission patterns is crucial for implementing targeted interventions and preventing further outbreaks.

Limited Medical Options and Vaccine Development

One of the most pressing challenges is the absence of approved vaccines or treatments for the Bundibugyo strain. While two potential vaccines are currently under consideration, experts estimate that it could take between three to nine months before they become available.

This delay leaves healthcare systems reliant on supportive care and preventive measures, such as isolation and hygiene practices, to control the spread.

The situation contrasts with previous outbreaks involving the Zaire strain, where vaccines and treatments were more readily available.

International Response and Funding Support

The global response to the outbreak has begun to take shape, with several countries pledging financial and logistical support. The United States has committed an initial $13 million to assist in containment efforts and plans to help establish 50 treatment clinics.

South Africa has also pledged $2.5 million through the Africa Centres for Disease Control and Prevention to support the response.

Additionally, cases involving international health workers have drawn attention. An American doctor infected with Ebola has been transferred to Germany for treatment, while another exposed doctor is being moved to the Czech Republic for monitoring.

Concerns Over Preparedness and Funding Gaps

Experts have raised concerns that delays in detecting the outbreak may reflect broader gaps in global health preparedness. Reductions in funding from major donors, including the United States, may have impacted surveillance and response capabilities.

While WHO officials have stated that it is too early to directly link funding cuts to the delayed response, the situation underscores the importance of sustained investment in public health systems.

Conclusion

The Ebola outbreak in the Democratic Republic of Congo presents a complex and evolving challenge. With evidence suggesting that the virus circulated undetected for months, combined with limited medical tools and resource constraints, the situation demands urgent and coordinated action.

As international support grows and containment efforts intensify, the focus remains on identifying transmission chains, improving healthcare capacity, and preventing further spread. The coming weeks will be critical in determining whether the outbreak can be brought under control.